bioRxivCancer BiologyPreprint
JAMMIT Analysis Defines 2 Semi-Independent Immune Processes Common to 29 Solid Tumors
E. Zitello, M. Vo, S. Bowler, S. Chen, T. Wenska, V. Khadka, P. Hoffmann, G. Okimoto, Y. Deng
Abstract
Immunophenotype of solid tumors has relevance to cancer immunotherapy, as not all patients respond optimally to treatment utilizing monoclonal antibodies. Bioinformatic studies have failed to clearly identify tumor immunophenotype in a way that encompasses a wide variety of tumor types and highlights fundamental differences among them, complicating prediction of patient clinical response. The novel JAMMIT algorithm was used to analyze mRNA data for 33 cancer types in The Cancer Genome Atlas (TCGA). We found that B cells and T cells constitute the principal source of variation in most patient cohorts, and that virtually all solid malignancies formed three hierarchical clustering patterns with similar molecular features. The second main source of variability in transcriptomic studies we attribute to monocytes. We identified the three tumor types as TC1-mediated, TC17-mediated and non-immunogenic immunophenotypes and used a 3-gene signature to approximate infiltration by agranulocytes. Methods of in silico validation such as pathway analysis, Cibersort and published data from treated cohorts were used to substantiate these findings. Monocytic infiltrate is found to be related to patient survival according to immunophenotype, important differences in some solid tumors are identified and deficiencies of common bioinformatic approaches relevant to diagnosis are detailed by this work.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: clustering
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: deep learning
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Application of the AMOCATI R workflow to tumor transcriptomic data delineates the adverse effect of immune cell infiltration in immune-privileged organs
Paul Régnier, Nicolas Cagnard, … Guillaume Darrasse-Jèze·bioRxiv·Jun 18, 2024
- Tumor-agnostic transcriptome-based classifier identifies spatial infiltration patterns of CD8+ T cells in the tumor microenvironment and predicts clinical outcome in early- and late-phase clinical trials
A. Roller, I. I. Davydov, … M. A. Cannarile·bioRxiv·Oct 2, 2023
- Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapy
X. Li, J. Eastham, … H. Koeppen·bioRxiv·Apr 3, 2023
- From tumor microenvironment to immuno-therapeutic outcomes for solid tumors: A systems theoretic approach
Priyan Bhattacharya, Rajanikanth Vadigepalli·bioRxiv·Sep 26, 2024
- A Pan-Cancer Census of Dominant Tumor Immune Archetypes
A. J. Combes, B. Samad, … M. F. Krummel·bioRxiv·Apr 26, 2021
- A pan-cancer landscape of interactions between solid tumors and infiltrating immune cell populations
David Tamborero, Carlota Rubio-Pérez, … Abel González-Pérez·Clinical Cancer ResearchPeer-reviewed·Apr 17, 2018